Streetbeat News

Analyst Ratings

RLAY

B of A Securities analyst Jason Gerberry maintains a Buy rating on Relay Therapeutics and raises the price target from $20 to $24.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:55 pm

CUBE

RBC Capital has initiated coverage on CubeSmart with an Outperform rating and set a price target of $56.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:54 pm

BFLY

Butterfly Network shares rose after Lake Street initiated coverage with a Buy rating and a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:53 pm

RBRK

Truist Securities analyst Joel Fishbein maintains a Buy rating on Rubrik (NYSE:RBRK) with a $43 price target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:50 pm

AAPL

JP Morgan analyst Samik Chatterjee has reiterated an Overweight rating on Apple (NASDAQ:AAPL) and maintained a price target of $265.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:49 pm

MEOH

Methanex Corp (NASDAQ:MEOH) is facing a downtrend after announcing a $2.05 billion acquisition of OCI Global's methanol business. Barclays analyst Mike Leithead downgraded Methanex to Equal-Weight, reducing the price target from $56 to $44, citing transaction risks and increased leverage as concerns.

Portfolio Pulse from Priya Nigam

September 10, 2024 | 3:48 pm

VRDN

BTIG analyst Julian Harrison has maintained a Buy rating on Viridian Therapeutics and raised the price target from $46 to $56, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:47 pm

JBI

Jefferies analyst Philip Ng maintains a Buy rating on Janus International Group (NYSE:JBI) but lowers the price target from $15 to $12.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:46 pm

DELL

Dell Technologies has seen a surge in options activity, with a significant portion of investors adopting a bullish stance. The options activity includes 26 notable trades, with a focus on a price range of $70 to $165. Analysts maintain positive ratings with target prices averaging $151.6.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 3:45 pm

MRVL

Unusual options activity has been observed for Marvell Tech (NASDAQ:MRVL), with significant interest from investors. The options activity is split between bullish and bearish sentiments, with a notable price target range of $52.5 to $95.0. Analysts have mixed ratings, with a consensus target price of $94.0.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 3:45 pm